CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a

R. C. Lyneham, J. G. Mcleod, I. D. Smith, Phillip Anson Low, R. P. Shearman, A. R. Korda

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Five of three hundred and twenty patients who had therapeutic second-trimester abortion by intra-amniotic prostaglandin F2a(P.G.F2a) experienced major convulsions during the procedure. In four out of eight patients there were abnormalities in serial electroencephalograms performed within one to four hours of P.G.F.2aadministration.

Original languageEnglish (US)
Pages (from-to)1003-1005
Number of pages3
JournalThe Lancet
Volume302
Issue number7836
DOIs
StatePublished - Nov 3 1973
Externally publishedYes

Fingerprint

Prostaglandins
Electroencephalography
Seizures
Second Pregnancy Trimester
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lyneham, R. C., Mcleod, J. G., Smith, I. D., Low, P. A., Shearman, R. P., & Korda, A. R. (1973). CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a The Lancet, 302(7836), 1003-1005. https://doi.org/10.1016/S0140-6736(73)91094-5

CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a . / Lyneham, R. C.; Mcleod, J. G.; Smith, I. D.; Low, Phillip Anson; Shearman, R. P.; Korda, A. R.

In: The Lancet, Vol. 302, No. 7836, 03.11.1973, p. 1003-1005.

Research output: Contribution to journalArticle

Lyneham, RC, Mcleod, JG, Smith, ID, Low, PA, Shearman, RP & Korda, AR 1973, 'CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a ', The Lancet, vol. 302, no. 7836, pp. 1003-1005. https://doi.org/10.1016/S0140-6736(73)91094-5
Lyneham, R. C. ; Mcleod, J. G. ; Smith, I. D. ; Low, Phillip Anson ; Shearman, R. P. ; Korda, A. R. / CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a In: The Lancet. 1973 ; Vol. 302, No. 7836. pp. 1003-1005.
@article{1f8151796b9445a58229e4a83aa27e47,
title = "CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a",
abstract = "Five of three hundred and twenty patients who had therapeutic second-trimester abortion by intra-amniotic prostaglandin F2a(P.G.F2a) experienced major convulsions during the procedure. In four out of eight patients there were abnormalities in serial electroencephalograms performed within one to four hours of P.G.F.2aadministration.",
author = "Lyneham, {R. C.} and Mcleod, {J. G.} and Smith, {I. D.} and Low, {Phillip Anson} and Shearman, {R. P.} and Korda, {A. R.}",
year = "1973",
month = "11",
day = "3",
doi = "10.1016/S0140-6736(73)91094-5",
language = "English (US)",
volume = "302",
pages = "1003--1005",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "7836",

}

TY - JOUR

T1 - CONVULSIONS AND ELECTROENCEPHALOGRAM ABNORMALITIES AFTER INTRA-AMNIOTIC PROSTAGLANDIN F2a

AU - Lyneham, R. C.

AU - Mcleod, J. G.

AU - Smith, I. D.

AU - Low, Phillip Anson

AU - Shearman, R. P.

AU - Korda, A. R.

PY - 1973/11/3

Y1 - 1973/11/3

N2 - Five of three hundred and twenty patients who had therapeutic second-trimester abortion by intra-amniotic prostaglandin F2a(P.G.F2a) experienced major convulsions during the procedure. In four out of eight patients there were abnormalities in serial electroencephalograms performed within one to four hours of P.G.F.2aadministration.

AB - Five of three hundred and twenty patients who had therapeutic second-trimester abortion by intra-amniotic prostaglandin F2a(P.G.F2a) experienced major convulsions during the procedure. In four out of eight patients there were abnormalities in serial electroencephalograms performed within one to four hours of P.G.F.2aadministration.

UR - http://www.scopus.com/inward/record.url?scp=0015821006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015821006&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(73)91094-5

DO - 10.1016/S0140-6736(73)91094-5

M3 - Article

C2 - 4127227

AN - SCOPUS:0015821006

VL - 302

SP - 1003

EP - 1005

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 7836

ER -